# EMPAVELI
> **NDA215014** · New Drug Application · Sponsor: APELLIS PHARMS · Approved 2021-05-14
## Drug
- **FDA Application Number:** NDA215014
- **Application type:** New Drug Application
- **Brand name:** EMPAVELI
- **Generic name:** PEGCETACOPLAN
- **Active ingredients:** PEGCETACOPLAN
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** APELLIS PHARMS
- **Manufacturer:** Apellis Pharmaceuticals, Inc.
- **First approval:** 2021-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215014)
---
*MORVS · CC0 1.0*